Abstract
Hyperpolarization-activated cyclic nucleotide-gated (HCN) channels play a critical role in controlling pacemaker activity in both heart and nervous system. Developing HCN channel inhibitors has been proposed to be an important strategy for the treatment of pain, heart failure, arrhythmias, and epilepsy. One HCN channel inhibitor, ivabradine, has been clinically approved for the treatment of angina pectoris and heart failure. In this study, we designed and synthesized eight alkanol amine derivatives, and assessed their effects on HCN channels expressed in COS7 cells using a whole-cell patch clamp method. Among them, compound 4e displayed the most potent inhibitory activity with an IC50 of 2.9 ± 1.2 µM at − 120 mV on HCN2 channel expressed in COS7 cells. Further analysis revealed that application of compound 4e (10 μM) caused a slowing of activation and a hyperpolarizing shift (ΔV1/2 = − 30.2 ± 2.9 mV, n = 5) in the voltage dependence of HCN2 channel activation. The inhibitory effect of compound 4e on HCN1 and HCN4 channel expressed in COS7 cells was less potent with IC50 of 17.2 ± 1.3 and 7.3 ± 1.2 μM, respectively. Besides, we showed that application of compound 4e (10 μM) inhibited Ih and action potential firing in acutely dissociated mouse small dorsal root ganglion neurons. Our study provides a new strategy for the design and development of potent HCN channel inhibitors.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
DiFrancesco D. Characterization of single pacemaker channels in cardiac sino-atrial node cells. Nature. 1986;324:470–3.
Proenza C, Angoli D, Agranovich E, Macri V, Accili EA. Pacemaker channels produce an instantaneous current. J Biol Chem. 2002;277:5101–9.
Baruscotti M, Bucchi A, Difrancesco D. Physiology and pharmacology of the cardiac pacemaker (“funny”) current. Pharmacol Ther. 2005;107:59–79.
Biel M, Wahl-Schott C, Michalakis S, Zong X. Hyperpolarization-activated cation channels: from genes to function. Physiol Rev. 2009;89:847–85.
Sartiani L, Mannaioni G, Masi A, Novella Romanelli M, Cerbai E. The hyperpolarization-activated cyclic nucleotide-gated channels: from biophysics to pharmacology of a unique family of ion channels. Pharmacol Rev. 2017;69:354–95.
DiFrancesco D, Tortora P. Direct activation of cardiac pacemaker channels by intracellular cyclic AMP. Nature. 1991;351:145–7.
Gauss R, Seifert R, Kaupp UB. Molecular identification of a hyperpolarization-activated channel in sea urchin sperm. Nature. 1998;393:583–7.
Wainger BJ, DeGennaro M, Santoro B, Siegelbaum SA, Tibbs GR. Molecular mechanism of cAMP modulation of HCN pacemaker channels. Nature. 2001;411:805–10.
Craven KB, Zagotta WN. CNG and HCN channels: two peas, one pod. Annu Rev Physiol. 2006;68:375–401.
Xu X, Vysotskaya ZV, Liu Q, Zhou L. Structural basis for the cAMP-dependent gating in the human HCN4 channel. J Biol Chem. 2010;285:37082–91.
Ludwig A, Zong X, Stieber J, Hullin R, Hofmann F, Biel M. Two pacemaker channels from human heart with profoundly different activation kinetics. EMBO J. 1999;18:2323–9.
Lorincz A, Notomi T, Tamas G, Shigemoto R, Nusser Z. Polarized and compartment-dependent distribution of HCN1 in pyramidal cell dendrites. Nat Neurosci. 2002;5:1185–93.
Dobrzynski H, Boyett MR, Anderson RH. New insights into pacemaker activity: promoting understanding of sick sinus syndrome. Circulation. 2007;115:1921–32.
Brioschi C, Micheloni S, Tellez JO, Pisoni G, Longhi R, Moroni P, et al. Distribution of the pacemaker HCN4 channel mRNA and protein in the rabbit sinoatrial node. J Mol Cell Cardiol. 2009;47:221–7.
Schulze-Bahr E, Neu A, Friederich P, Kaupp UB, Breithardt G, Pongs O, et al. Pacemaker channel dysfunction in a patient with sinus node disease. J Clin Invest. 2003;111:1537–45.
Baruscotti M, Bucchi A, Viscomi C, Mandelli G, Consalez G, Gnecchi-Rusconi T, et al. Deep bradycardia and heart block caused by inducible cardiac-specific knockout of the pacemaker channel gene Hcn4. Proc Natl Acad Sci U S A. 2011;108:1705–10.
Duhme N, Schweizer PA, Thomas D, Becker R, Schroter J, Barends TRM, et al. Altered HCN4 channel C-linker interaction is associated with familial tachycardia-bradycardia syndrome and atrial fibrillation. Eur Heart J. 2013;34:2768–75.
Milano A, Vermeer AM, Lodder EM, Barc J, Verkerk AO, Postma AV, et al. HCN4 mutations in multiple families with bradycardia and left ventricular noncompaction cardiomyopathy. J Am Coll Cardiol. 2014;64:745–56.
Nava C, Dalle C, Rastetter A, Striano P, de Kovel CG, Nabbout R, et al. De novo mutations in HCN1 cause early infantile epileptic encephalopathy. Nat Genet. 2014;46:640–5.
Postea O, Biel M. Exploring HCN channels as novel drug targets. Nat Rev Drug Discov. 2011;10:903–14.
Thollon C, Cambarrat C, Vian J, Prost JF, Peglion JL, Vilaine JP. Electrophysiological effects of S 16257, a novel sino-atrial node modulator, on rabbit and guinea-pig cardiac preparations: comparison with UL-FS 49. Br J Pharmacol. 1994;112:37–42.
Bois P, Bescond J, Renaudon B, Lenfant J. Mode of action of bradycardic agent, S 16257, on ionic currents of rabbit sinoatrial node cells. Br J Pharmacol. 1996;118:1051–7.
BoSmith RE, Briggs I, Sturgess NC. Inhibitory actions of ZENECA ZD7288 on whole-cell hyperpolarization activated inward current (If) in guinea-pig dissociated sinoatrial node cells. Br J Pharmacol. 1993;110:343–9.
Cheng L, Kinard K, Rajamani R, Sanguinetti MC. Molecular mapping of the binding site for a blocker of hyperpolarization-activated, cyclic nucleotide-modulated pacemaker channels. J Pharmacol Exp Ther. 2007;322:931–9.
Shin KS, Rothberg BS, Yellen G. Blocker state dependence and trapping in hyperpolarization-activated cation channels: evidence for an intracellular activation gate. J Gen Physiol. 2001;117:91–101.
Bucchi A, Tognati A, Milanesi R, Baruscotti M, DiFrancesco D. Properties of ivabradine-induced block of HCN1 and HCN4 pacemaker channels. J Physiol. 2006;572:335–46.
Bucchi A, Baruscotti M, Nardini M, Barbuti A, Micheloni S, Bolognesi M, et al. Identification of the molecular site of ivabradine binding to HCN4 channels. PLoS One. 2013;8:e53132.
Melchiorre M, Del Lungo M, Guandalini L, Martini E, Dei S, Manetti D, et al. Design, synthesis, and preliminary biological evaluation of new isoform-selective f-current blockers. J Med Chem. 2010;53:6773–7.
Del Lungo M, Melchiorre M, Guandalini L, Sartiani L, Mugelli A, Koncz I, et al. Novel blockers of hyperpolarization-activated current with isoform selectivity in recombinant cells and native tissue. Br J Pharmacol. 2012;166:602–16.
Stieber J, Wieland K, Stockl G, Ludwig A, Hofmann F. Bradycardic and proarrhythmic properties of sinus node inhibitors. Mol Pharmacol. 2006;69:1328–37.
Gill CH, Randall A, Bates SA, Hill K, Owen D, Larkman PM, et al. Characterization of the human HCN1 channel and its inhibition by capsazepine. Br J Pharmacol. 2004;143:411–21.
Schnorr S, Eberhardt M, Kistner K, Rajab H, Kasser J, Hess A, et al. HCN2 channels account for mechanical (but not heat) hyperalgesia during long-standing inflammation. Pain. 2014;155:1079–90.
Bischoff U, Brau ME, Vogel W, Hempelmann G, Olschewski A. Local anaesthetics block hyperpolarization-activated inward current in rat small dorsal root ganglion neurones. Br J Pharmacol. 2003;139:1273–80.
Yao H, Donnelly DF, Ma C, LaMotte RH. Upregulation of the hyperpolarization-activated cation current after chronic compression of the dorsal root ganglion. J Neurosci. 2003;23:2069–74.
Young GT, Emery EC, Mooney ER, Tsantoulas C, McNaughton PA. Inflammatory and neuropathic pain are rapidly suppressed by peripheral block of hyperpolarisation-activated cyclic nucleotide-gated ion channels. Pain. 2014;155:1708–19.
Yi F, Danko T, Botelho SC, Patzke C, Pak C, Wernig M, et al. Autism-associated SHANK3 haploinsufficiency causes I h channelopathy in human neurons. Science. 2016;352:aaf2669.
Berta T, Qadri Y, Tan PH, Ji RR. Targeting dorsal root ganglia and primary sensory neurons for the treatment of chronic pain. Expert Opin Ther Targets. 2017;21:695–703.
Momin A, Cadiou H, Mason A, McNaughton PA. Role of the hyperpolarization-activated current I h in somatosensory neurons. J Physiol. 2008;586:5911–29.
Emery EC, Young GT, Berrocoso EM, Chen L, McNaughton PA. HCN2 ion channels play a central role in inflammatory and neuropathic pain. Science. 2011;333:1462–6.
Acknowledgements
This work was supported by research grants from the National Natural Science Foundation of China 81503042 and Pearl River Nova Program of Guangzhou 201605111735229 (to PZ).
Author information
Authors and Affiliations
Contributions
S-jC, YX and P-zZ designed the research; S-jC, Y-mL and YC performed the electrophysiological experiments; YX, J-yL and J-xP contributed new compounds; S-jC, YX and P-zZ analyzed the data and wrote the paper.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no competing interest.
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Chen, Sj., Xu, Y., Liang, Ym. et al. Identification and characterization of a series of novel HCN channel inhibitors. Acta Pharmacol Sin 40, 746–754 (2019). https://doi.org/10.1038/s41401-018-0162-z
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/s41401-018-0162-z
Keywords
This article is cited by
-
Insights into ion channels to identify drug target for neuropathic pain management
Inflammopharmacology (2025)
-
Cardiac and neuronal HCN channelopathies
Pflügers Archiv - European Journal of Physiology (2020)
